Biohaven Ltd. ( BHVN) - Stock Earnings
BHVN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -173.4 million USD | — USD |
| 2025Q4 | -145.6 million USD | — USD |
| 2026Q1 | -130.5 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BHVN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -408.2 million USD | — USD |
| 2024 | -846.4 million USD | — USD |
| 2025 | -738.8 million USD | — USD |
| 2026 Est. | — | — |
BHVN
Price: $12.14
52 week price:
Earnings Per Share: -5.57 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 704100
Ebitda: -42.6 millionMarket Capitalization: 1.1 billion